Background: Even though the presence of antithyroglobulin antibodies (TgAbs) represents a
significant problem in the follow-up of patients with differentiated thyroid cancer (DTC), the …

Purpose: This study evaluated the impact of 124 I-positron emission tomography (PET)
dosimetry on post-primary surgery therapy in radioiodine-naive patients with advanced …

The procedure guideline for radioiodine therapy (RIT) of differentiated thyroid cancer
(version 3) is the counterpart to the procedure guideline for 131 I whole-body scintigraphy …

When thyroid tissues exhibited concentrations of therapeutic 131I that appeared to be less
than that predicted by data from the preceding diagnostic 131I, the phenomenon was called …

Objective: Dosimetry studies have shown that activities of 131 I as small as 10-20 MBq may
cause a stunning effect. A result of this stunning effect may be a lower success rate of the …

Version 3 of the procedure guideline for 131 I whole-body scintigraphy (WBS) is the
counterpart to the procedure guideline for radioiodine therapy (version 3) and specify the …

Purpose In radioiodine therapy the “stunning phenomenon” is defined as a reduction of
radioiodine uptake after diagnostic application of 131 I. In the current study, we established …

Zusammenfassung Die Version 4 der Verfahrensanweisung zur Radioiodtherapie (RIT)
beim differenzierten Schilddrüsenkarzinom ist ein umfassendes Update der Version 3, die …

Iodine is an essential element and yet is poorly represented in matrix reference materials. In
this paper a novel development of the double IDMS equation using 129I spike is presented …

Die Verfahrensanweisung zur Radioiodtherapie beim differenzierten Schilddrüsenkarzinom
(Version 4) wurde von einer repräsentativen Expertengruppe im informellen Konsens …